Vetter has been producing sterile liquid and lyophilized drugs for over 25 years. The company’s focus is on aseptically pre-filled injection systems. Vetter is experienced in using a large array of standard injection systems, cartridge systems and its own patented dual-chamber application systems. Priority has always been on meeting the highest international standards of quality. Furthermore, all of its products and processes have been designed and tested in accordance with international cGMP standards (i.e. FDA, EMEA). Its customers can be assured that their product is in excellent hands. Vetter Commercial Manufacturing handles all aspects of drug production from sterile filling to custom-packing of the final product. A full range of cutting-edge technology is deployed to guarantee sterile production, such as Restricted Access Barrier Systems (RABS). Liquid parenteral drugs and lyophilized drugs are manufactured in the company’s own state-of-the-art manufacturing sites. This allows Vetter to provide a complete package of services (form, fill and finish) in the production of modern biopharmaceutical drugs. All products and processes are monitored by a quality assurance system to ensure conformity with the agreed quality specifications and regulatory requirements.
You have successfully subscribed and will receive the next available issues